Carlo Bifulco
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 40
- CAR-T cell therapy research 19
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 10
- Immunology top 2%
- Immunotherapy and Immune Responses 33
- Immune Cell Function and Interaction 6
- Immune cells in cancer 6
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 12
-
- Colorectal and Anal Carcinomas 8
- Co-authors
- Bernard A. FoxRom S. LeidnerCarlo ParraviciniR. Bryan BellElisa FeudaleFranco RilkeFred H. ReynoldsGiorgio Cattoretti
- Journals
- Journal for ImmunoTherapy of Cancer (16 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (5 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Carlo Bifulco
102 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 1.8k
- Otorhinolaryngology 242
- Immunology 1.1k
- Cancer Research 347
- Pathology and Forensic Medicine 296
Countries citing papers authored by Carlo Bifulco
This map shows the geographic impact of Carlo Bifulco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Bifulco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Bifulco more than expected).
Fields of papers citing papers by Carlo Bifulco
This network shows the impact of papers produced by Carlo Bifulco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Bifulco. The network helps show where Carlo Bifulco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carlo Bifulco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 19 | |
| 6 | 2023 | 18 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 114 | |
| 9 | 2021 | 120 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 2 | |
| 12 | 2019 | 35 | |
| 13 | 2017 | 46 | |
| 14 | 2017 | 10 | |
| 15 | 2016 | 209 | |
| 16 | 2015 | 15 | |
| 17 | 2014 | 29 | |
| 18 | 2008 | 58 | |
| 19 | 2008 | 20 | |
| 20 | 2002 | 29 |
About Carlo Bifulco
Carlo Bifulco is a scholar working on Oncology, Otorhinolaryngology, Immunology, Cancer Research and Genetics, having authored 106 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (40 papers), Immunotherapy and Immune Responses (33 papers), CAR-T cell therapy research (19 papers), Cancer Genomics and Diagnostics (12 papers), Head and Neck Cancer Studies (10 papers), Colorectal and Anal Carcinomas (8 papers), Immune Cell Function and Interaction (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Oncology (1.8k citations), Otorhinolaryngology (242 citations), Immunology (1.1k citations), Cancer Research (347 citations) and Pathology and Forensic Medicine (296 citations). Carlo Bifulco has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Bernard A. Fox, Rom S. Leidner, Carlo Parravicini, R. Bryan Bell, Elisa Feudale, Franco Rilke, Fred H. Reynolds, Giorgio Cattoretti, Elena Sabattini and Johannes Gerdes. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Annals of Oncology, The Journal of Immunology and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.